Literature DB >> 1352013

Growth of human umbilical-cord blood in longterm haemopoietic cultures.

J M Hows1, B A Bradley, J C Marsh, T Luft, L Coutinho, N G Testa, T M Dexter.   

Abstract

Cryopreserved human umbilical-cord (HUC) blood is an alternative to bone marrow as a source of haemopoietic "stem" cells for HLA-identical transplantation of children with leukaemia or Fanconi's anaemia. We have studied the in-vitro growth potential of HUC blood in clonogenic assays and in longterm haemopoietic cultures. Clonogenic assays showed that HUC blood produced as many haemopoietic-cell colonies as normal adult bone marrow and a higher proportion of primitive-cell colonies. In longterm culture on preformed irradiated marrow stroma, both progenitor-cell production and lifespan of cultures were significantly greater in HUC blood than in normal bone marrow (p = 0.0007). Our findings indicate that the quality and quantity of HUC-blood-derived haemopoietic "stem" cells are better than those of normal bone marrow. Therefore, single HUC-blood donations are probably sufficient for adults requiring transplantation for leukaemia and other haemopoietic disorders. Banking of HLA-typed HUC blood to facilitate transplantation of patients who lack a family donor should be considered.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352013     DOI: 10.1016/0140-6736(92)90396-k

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  19 in total

Review 1.  Cord blood stem cells for hematopoietic transplantation.

Authors:  Anfisa Stanevsky; Avichai Shimoni; Ronit Yerushalmi; Arnon Nagler
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

2.  What is the future for cord blood stem cells?

Authors:  E A de Wynter
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

Review 3.  Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine.

Authors:  Patricia Flores-Guzmán; Verónica Fernández-Sánchez; Hector Mayani
Journal:  Stem Cells Transl Med       Date:  2013-10-07       Impact factor: 6.940

4.  Long-term culture system for selective growth of human B-cell progenitors.

Authors:  D J Rawlings; S G Quan; R M Kato; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

5.  Establishment of an adherent cell feeder layer from human umbilical cord blood for support of long-term hematopoietic progenitor cell growth.

Authors:  Z Q Ye; J K Burkholder; P Qiu; J C Schultz; N T Shahidi; N S Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

6.  Neonatal prevention of iron deficiency. Placental transfusion might reduce prevalence of iron deficiency.

Authors:  G Markey; T C Morris
Journal:  BMJ       Date:  1996-04-27

7.  Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.

Authors:  P Rubinstein; L Dobrila; R E Rosenfield; J W Adamson; G Migliaccio; A R Migliaccio; P E Taylor; C E Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

Review 8.  Umbilical cord blood research: current and future perspectives.

Authors:  Jennifer D Newcomb; Paul R Sanberg; Stephen K Klasko; Alison E Willing
Journal:  Cell Transplant       Date:  2007       Impact factor: 4.064

9.  Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults.

Authors:  A A Cardoso; M L Li; P Batard; A Hatzfeld; E L Brown; J P Levesque; H Sookdeo; B Panterne; P Sansilvestri; S C Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

10.  Separation, enrichment, and characterization of human hematopoietic progenitor cells from umbilical cord blood.

Authors:  J H Falkenburg; S A van Luxemburg-Heijs; J M Zijlmans; W E Fibbe; J C Kluin-Nelemans; H H Kanhai; R Willemze
Journal:  Ann Hematol       Date:  1993-11       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.